-
TTS Pharma is the first UK manufacturer to produce commercial cannabidiol free of illegal THC and CBN
Sep 19, 2019, 06:47 AM by Michael CroftLIVERPOOL AND LONDON, UK - Sep 19, 2019 - TTS Pharma Limited, a producer of the highest quality, legal and safe cannabinoids (including Cannabidiol (CBD)) for use in food, cosmetics and nutraceuticals, today announces the results of an independent analysis of its CBD oilFull story -
Creative Proteomics Released Sequence Analysis of Peptides or Protein for Research Use
Sep 19, 2019, 03:11 AM by Michael CroftSHIRLEY, NY - Sep 18, 2019 - September 18, 2019, Creative Proteomics, as a leading supplier in the fields of proteomics, glycomics, metabolomics and bioinformatics, recently released the protein sequence analysis to assist researchers in their biological projectsFull story -
Benchling Launches New Products for Research Institutions and Biotech Startups to Accelerate Life Science Innovation
Sep 17, 2019, 12:31 PM by Michael CroftSAN FRANCISCO, CA - Sep 17, 2019 - Benchling, the leading life sciences R&D cloud platform, today took a major step forward in democratizing access to its industry-leading data management and collaboration software by launching Benchling for Institutions and Benchling for StartupsFull story -
Deloitte and AVIA Expand Relationship and Commit to Strategic Collaboration for Healthcare Innovation and Transformation
Sep 17, 2019, 10:44 AM by Michael CroftCHICAGO, IL, UNITED STATES - Sep 17, 2019 - Chicago, IL – AVIA, the leading partner for digital health insights, strategic guidance, and consulting services, announced today that it is expanding its relationship with Deloitte, the industry-leading audit, consulting, tax, and advisory services organizationFull story -
WCG KMR Group Invites Biopharmaceutical Companies to Enroll in Clinical Trial Cost Study
Sep 17, 2019, 10:13 AM by Michael CroftPRINCETON, NJ - Sep 17, 2019 - The WIRB-Copernicus Group®s (WCG) Clinical Services Division is pleased to announce that enrollment in WCG KMR Groups 2019 Clinical Trial Cost Study is now openFull story -
Celsee Issued New Patent for Single-Cell Capture System
Sep 17, 2019, 09:18 AM by Michael CroftANN ARBOR, MI, UNITED STATES - Sep 17, 2019 - Celsee, Inc., today announced the issuance of U.S. Patent No. 10,416,070, entitled Cell capture system and method of use, which covers the automation of single-cell partitioningFull story -
Certara Introduces its Hasharc Decentralized Application for Healthcare at the Launch of Hedera Hashgraph Open Access
Sep 17, 2019, 08:30 AM by Michael CroftPRINCETON, NJ - Sep 17, 2019 - Certara®, the global model-informed drug development and decision support leader, today announced the launch of Hasharc, its decentralized application (DApp) for healthcare, built in conjunction with the Hedera public Distributed Ledger Technology (DLT)Full story -
Creative Biolabs Provides Anti-CXCR4 Antibody for Research Use
Sep 17, 2019, 03:09 AM by Michael CroftSHIRLEY, NY - Sep 16, 2019 - September 16, 2019, Creative Biolabs, as a leading supplier in antibody production field, recently announced anti cxcr4 antibody and the related anti-cxcr4 dasatinib to assist researchers research projectsFull story -
Everest Medicines Expands Senior Leadership Team
Sep 16, 2019, 12:50 PM by Michael CroftNEW YORK, NY, UNITED STATES - Sep 16, 2019 - Shanghai and New York - September 16, 2019 - Everest Medicines, a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in Greater China and other parts of Asia, today announced Everest Medicine's founding member, DrFull story -
Could Using CRISPR To Edit Embryos Save People Who Are Already Alive?
Sep 16, 2019, 12:41 PM by Michael CroftSTAT | The technology is not advanced enough yet, but the idea of editing DNA to produce a savior sibling may be theoretically possible.Full story -
Space Is The New Frontier For Life Sciences Research
Sep 16, 2019, 07:35 AM by Michael CroftFull storyBio-IT World | Advances in microfluidics, the shift from animal-based to cell-based models of drug research, and the ability to grow larger and more perfect protein crystals in microgravity have all helped propel space-based research into a thriving commercial enterprise.
-
Glowing Cholesterol A Game-Changer For Study Of Heart Disease
Sep 13, 2019, 10:05 AM by Michael CroftFull storyBio-IT World | A new technique that lights up a protein shuttling LDL cholesterol around the circulatory system has made it financially feasible to do high-throughput screening for cardiovascular drugs as well as measure the size of LDL particles—an important but poorly-understood disease risk factor.
-
Why Aren’t There Better Cancer Drugs? Scientists May Have Picked the Wrong Targets
Sep 12, 2019, 09:36 AM by Michael CroftThe New York Times | Drugs can stop cancer cells if they attack the right proteins. But many of these targets were chosen with dated, imprecise technology, a new study suggests.Full story -
National Maternal and Infant Health Crisis Spurs 30 Health Systems to Take Action
Sep 12, 2019, 09:20 AM by Michael CroftCHICAGO, IL, UNITED STATES - Sep 12, 2019 - CHICAGO - September 12, 2019 - In response to the national maternal health epidemic, 30 large health systems are banding together to find and put forward solutions to this crisis in their communitiesFull story -
Signant Health Brings Its eConsent Solution to China for Large Neuroscience Study in Collaboration with Shanghai Mental Health Center
Sep 12, 2019, 09:14 AM by Michael CroftPHILADELPHIA, PA, US - Sep 12, 2019 - Signant Health (formerly CRF Health and Bracket), a leading patient-centric technology company, has been selected to provide electronic informed consent for a significant neuroscience study by the prestigious Shanghai Mental Health Center (SMHC)Full story -
Shimmer Announces Launch of Healthcare Industry Open Source Initiative for Wearable Sensor Algorithms
Sep 12, 2019, 08:58 AM by Michael CroftCAMBRIDGE, MA - Sep 12, 2019 - Shimmer Research, a global leader in wearable technology for research applications, today announced the launch of a healthcare industry open source initiative for wearable sensor algorithmsFull story -
Certara Launches Version 8.2 of its Industry-leading Phoenix PK/PD Modeling and Simulation Software for Drug Development
Sep 12, 2019, 08:42 AM by Michael CroftPRINCETON, NJ - Sep 12, 2019 - Certara®, the global model-informed drug development and decision support leader, today announced the launch of Phoenix® 8Full story -
TraceLink Demonstrates Continued Global Momentum with Strong Q2 2019 Results
Sep 12, 2019, 06:50 AM by Michael Croft, UNITED KINGDOM - Sep 12, 2019 - 75 percent increase in new U.S. bookings, large revenue growth in APAC and India, and largest FutureLink conference to date among highlights North Reading, MA (August XX, 2019)-TraceLink IncFull story -
Supporting medical researchers working with large complex datasets of proteins, genes and metabolites
Sep 12, 2019, 06:26 AM by Michael CroftGUILDFORD, UNITED KINGDOM - Sep 12, 2019 - OverviewYale University in Connecticut, USA, owns one of the world's great medical historical librariesFull story -
Sharp Expands its Clinical Operations to European Facility
Sep 12, 2019, 05:41 AM by Michael CroftHEERENVEEN, NETHERLANDS - Sep 12, 2019 - Sharp - part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, has received Wholesale Distribution Authorisation (WDA) and Investigational Medicinal Product (IMP) licensing approvals to support clinical activities from its facility in Heerenveen, NetherlandsFull story